• HC Wainwright Reaffirms "Buy" Rating for Apellis Pharmaceuticals (NASDAQ:APLS)

    Source: Buzz FX / 14 Jan 2025 08:16:16   America/New_York


    HC Wainwright Reaffirms "Buy" Rating for Apellis Pharmaceuticals (NASDAQ:APLS) Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Apellis Pharmaceuticals ( NASDAQ:APLS - Get Free Report ) 's stock had its "buy" rating re
    Read more...
Share on,